Antiplatelet for Coronary Artery Disease in Specific Condition “No Size Fits All”

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|24|4|478-495

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.24, Iss.4, 2018-04, pp. : 478-495

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Challenges and Perspectives of Antiplatelet Therapy in Patients with Diabetes Mellitus and Coronary Artery Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5273-5293

Bentham Science Publishers

Access to resources Recommend Favorite

An alternative to ‘one size fits all’

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 3, 2005-03 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

NSAIDs increase CV risk in coronary artery disease

By  

Reactions Weekly, Vol. 1, Iss. 1363, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Candesartan CREATEs promise in coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Celecoxib: beneficial effects in coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite